MolNFT v1 · #182915 · protein
AlphaFold monomer V2.0 prediction for alpha-amylase inhibitor aai (P80403)
P80403: “AlphaFold monomer V2.0 prediction for alpha-amylase inhibitor aai (P80403)”. MolNFT v1 #182915 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- P80403
- Type
- protein
- Length
- 32 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0xEa58c7534E5701aA8370E0fAEb19b7e14653e69c
- UniProt
- P80403
Structure
1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 32 | — | P80403 |
Compared structures
- 1CLV · Yellow meal worm alpha-amylase in complex with the amaranth alpha-amylase inhibitor · an experimental structure of the same protein · chain A against I, TM-score 0.90
- 1CLV · Yellow meal worm alpha-amylase in complex with the amaranth alpha- amylase inhibitor · an experimental structure of the same protein · chain A against I, TM-score 0.90
- 1QFD · NMR solution structure of alpha-amylase inhibitor (aai) · an experimental structure of the same protein · chain A against A, TM-score 0.73
- 1QFD · NMR solution structure of alpha-amylase inhibitor (aai) · an experimental structure of the same protein · chain A against A, TM-score 0.73
- 1HTX · Solution structure of the main alpha-amylase inhibitor from amaranth seeds · an experimental structure of the same protein · chain A against A, TM-score 0.72
- 1HTX · Solution structure of the main alpha-amylase inhibitor from amaranth seeds · an experimental structure of the same protein · chain A against A, TM-score 0.72
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P80403
- Elsewhere: UniProt P80403 · AlphaFold DB P80403
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.